Nomura Asset Management CO LTD Zymeworks Inc. Transaction History

Nomura Asset Management CO LTD

11 transactions

Quarter	Operation	Price Per share	shares change
Q1 2022 May 13, 2022	SELL	$6.0 - $16.98 $0 - $0	0 Closed
Q4 2021 Feb 01, 2022	BUY	$15.19 - $29.33 $0 - $0	0 New
Q3 2021 Nov 12, 2021	BUY	$27.35 - $37.28 $0 - $0	0 New
Q2 2021 Aug 06, 2021	BUY	$26.5 - $38.23 $0 - $0	0 New
Q1 2021 May 14, 2021	BUY	$29.83 - $56.81 $0 - $0	0 New
Q4 2020 Feb 12, 2021	BUY	$39.12 - $54.99 $0 - $0	0 New
Q3 2020 Nov 12, 2020	BUY	$29.21 - $46.58 $0 - $0	0 New
Q2 2020 Aug 13, 2020	BUY	$33.67 - $40.0 $0 - $0	0 New
Q1 2020 May 14, 2020	BUY	$24.28 - $49.8 $0 - $0	0 New
Q4 2019 Feb 13, 2020	BUY	$24.84 - $45.46 $0 - $0	0 New
Q3 2019 Nov 13, 2019	BUY	$22.78 - $29.08 $0 - $0	0 New

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $872M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.